Novo Nordisk A S annual gross margin
2019
2020
2021
2022
2023
2024
2025
Novo Nordisk A S's gross margin was 80.98% for fiscal 2025.
View full Novo Nordisk A S company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 80.98% | −3.69 pp |
| 2024 | 2024-12-31 | 84.67% | +0.07 pp |
| 2023 | 2023-12-31 | 84.60% | +0.68 pp |
| 2022 | 2022-12-31 | 83.92% | +0.73 pp |
| 2021 | 2021-12-31 | 83.20% | −0.31 pp |
| 2020 | 2020-12-31 | 83.51% | −0.03 pp |
| 2019 | 2019-12-31 | 83.54% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 78.21% | −5.28 pp |
| Q1 2026 | 2026-03-31 | 85.96% | +1.34 pp |
| Q3 2025 | 2025-09-30 | 81.02% | −3.85 pp |
| Q2 2025 | 2025-06-30 | 83.39% | −1.44 pp |
| Q1 2025 | 2025-03-31 | 83.49% | — |
| Q3 2024 | 2024-09-30 | 84.61% | — |
| Q2 2024 | 2024-06-30 | 84.87% | — |
| Q1 2024 | 2024-03-31 | 84.83% | — |
Over the last five reported fiscal years, Novo Nordisk A S's gross margin decreased from 83.51% to 80.98%, a change of −2.53 percentage points. The latest reported quarter, Q2 2026, shows 78.21%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Novo Nordisk A S filings at SEC.gov ↗